We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tate & Lyle Plc | LSE:TATE | London | Ordinary Share | GB00BP92CJ43 | ORD 29 1/6P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 1.00 | 0.15% | 654.00 | 383,626 | 16:21:31 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 653.50 | 654.50 | 667.50 | 652.00 | 667.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Flavoring Extract,syrup, Nec | 1.65B | 188M | 0.4180 | 15.62 | 2.94B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:23:46 | O | 5 | 654.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 27/12/2024 | 17:15 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 23/12/2024 | 17:26 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 20/12/2024 | 17:31 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 19/12/2024 | 17:24 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 18/12/2024 | 17:37 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 17/12/2024 | 17:20 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 16/12/2024 | 17:37 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 13/12/2024 | 17:25 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 12/12/2024 | 17:34 | UK RNS | Tate & Lyle PLC Transaction in Own Shares |
| 12/12/2024 | 17:30 | UK RNS | Tate & Lyle PLC Director/PDMR Shareholding |
Tate & Lyle (TATE) Share Charts1 Year Tate & Lyle Chart |
|
1 Month Tate & Lyle Chart |
Intraday Tate & Lyle Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 16/12/2024 | 14:28 | Tate and Lyle Graph's and Charts | 3,987 |
| 26/11/2021 | 16:20 | TATE Charts | 38 |
| 22/5/2019 | 12:29 | Tate & Lyle FY Preview 23.05.19 | - |
| 03/7/2014 | 08:18 | Darren Sinden bullish on Tate & Lyle PLC live on TipTV | - |
| 10/9/2013 | 04:52 | TATE sweet & sour | 103 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 16:23:46 | 654.50 | 5 | 32.73 | O |
| 16:21:32 | 653.50 | 467 | 3,051.85 | O |
| 16:21:31 | 654.00 | 466 | 3,047.64 | AT |
| 16:21:31 | 654.00 | 224 | 1,464.96 | AT |
| 16:21:31 | 654.00 | 269 | 1,759.26 | AT |
| Top Posts |
|---|
Posted at 30/12/2024 08:20 by Tate & Lyle Daily Update Tate & Lyle Plc is listed in the Flavoring Extract,syrup, Nec sector of the London Stock Exchange with ticker TATE. The last closing price for Tate & Lyle was 653p.Tate & Lyle currently has 449,717,461 shares in issue. The market capitalisation of Tate & Lyle is £2,936,655,020. Tate & Lyle has a price to earnings ratio (PE ratio) of 15.62. This morning TATE shares opened at 667.50p |
Posted at 09/12/2024 09:24 by nash19 I'm really shocked at the dilution and lack of impact from CP. All the while tate wants its valuation to go up.I see synergies, already low, disappointing from here and concerns about growth building.600p back in the front window. |
Posted at 05/12/2024 14:38 by nash19 Looks like a long March back down now for tate after the FT puff piece has turned out to be garbage.The dilution from CP deal looks butt ugly for new couple of years. |
Posted at 23/10/2024 08:52 by roguetraderuk potential acquirer often feeds the media in an attempt to force shareholders to put pressure on the management to engage in talks or accept a bid. in the age of short-termism its a tool that yields results especially if underlying share price has been underperforming. |
Posted at 23/10/2024 08:37 by cfro Yep, it's a weird old investing world. I think it's funny that most uk based investors have practically given-up on the uk market and would rather put their money in the US particularly the mag 7 stocks.These same investors fail to see the opportunities we have here like TATE a world leading food science company. Whereas American investors do see the opportunity and want it for their own. Isn't it ironic.. For that reason i rather hope this doesn't get taken-out. It was a bit of a strange article in the FT a few days ago. One wonders how that came about and where that news came from. |
Posted at 16/10/2024 20:10 by laurence llewelyn binliner #Nash19, Huber will become a long-term shareholder c16% in Tate & Lyle following the CP Kelco completion. The potential for Huber to become a long-term shareholder and participate in the future value creation from the combination of the two businesses was central to unlocking a transaction.A great start for them too.. :o) See what the week brings in terms of an offer RNS (or not) from Advent.. |
Posted at 15/10/2024 19:07 by laurence llewelyn binliner Very nice too.. :o), still a way back to 800 and the 6:7 post consolidation share price back in May 2022, then we dropped a 105 pence on the special dividend payout..As the CP Kelco merger concludes we will start to see economies of scale come through, It is a hold from me.. |
Posted at 04/10/2024 12:19 by wad collector Tucked into a lengthy notice about the Kelco merger/takeover yesterday , and how they no longer need shareholder votes to complete it , is a TU:Trading update Standalone Tate & Lyle (excluding CP Kelco) For the five months ended 31 August 2024 Tate & Lyle is seeing positive volume momentum, with trading in line with our expectations. The outlook for the year ending 31 March 2025 is unchanged. Management continue to expect to deliver in constant currency: · Revenue slightly lower than the prior year · EBITDA growth of between 4% and 7%. CP Kelco For the eight months ended 31 August 2024, financial performance continues to stabilise with volume well ahead of the comparative period. |
Posted at 28/8/2024 12:36 by laurence llewelyn binliner Nice recovery here from the 600 low at the CP Kelco buy out news back in mid June, as the merger progresses we will see economies of scale and cost saving synergies shine through as well as increased revenues/margins/pro75M new shares issued for the deal with the 16% dilution almost now recovered in the share price.. 700 pence coming into view for starters.. :o) |
Posted at 20/6/2024 13:27 by laurence llewelyn binliner Still 16% dilution with the new equity issuance however you cut it, plus the new debt load, the BB was supposed to be a 'sweetener' to shore up the share price on the XD, BUT a much bigger company going forward with cost saving synergies and the increase in EBITDA..A buying opportunity for the long term IMO, limit orders seems to be getting triggered at 600 pence.. :o) The Proposed Transaction is expected to be accretive to adjusted earnings per share, including cost synergies only, in the second full financial year following completion, and strongly accretive thereafter. · Return on invested capital expected to exceed Tate & Lyles weighted average cost of capital in the fifth full year following completion. · Targeted run-rate cost synergies of at least US$50 million (GBP40M) by the end of the second full financial year following completion, with 50% - 60% (or cUSD25M) of cost synergies to be realised by the end of the first full financial year following completion. The cost to deliver these synergies is estimated to be around US$75 million. There is also significant opportunity to accelerate revenue growth and, over the medium term, we are targeting revenue synergies of up to 10% of CP Kelcos revenue. No change to Tate & Lyles existing approach to capital allocation and dividend policy.. |
Posted at 20/6/2024 13:07 by suetballs The Board of tate must be stunned by the share price reaction.I certainly didn't expect it. Suet |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
